Translational Development Acquisition (TDACW) Net Cash Flow Growth (1y) (2025 - 2026)
Powered by 
Analysis
Translational Development Acquisition (TDACW) Net Cash Flow Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn | 548.30% |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn | - |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn | -582.23% |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - | 51.71% |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - | -743.28% |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - | 553.88% |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | 188.74% |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | -15,982.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,982.28% |
| Mar 31, 2026 | 97.77% |
| Dec 31, 2025 | -100.01% |
| Sep 30, 2025 | -145.77% |